![](/wp-content/uploads/2023/02/Screenshot-2023-02-01-at-5.11.40-PM.png)
$599
Amgen, Novartis, and Lannett Q4 ’22 Earnings Updates
A series of cardiometabolic-related news items have been observed. Amgen (press release; slides), Novartis (press release; slides), and Lannett (press release) hosted their respective Q4 2022 earnings calls. Below, FENIX provides highlights and insights from the earnings calls.